Healthy Skepticism Library item: 11662

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Health Canada withdraws Prexige from market
Reuters 2007 Oct 4
http://www.reuters.com/article/healthNews/idUSN0438584020071004

Full text:

TORONTO (Reuters) – Health Canada said on Thursday that it has stopped the sale of Novartis Pharmaceuticals Canada Inc’s anti-inflammatory drug Prexige and will cancel its market authorization due to the risk for serious liver-related effects including hepatitis.

The agency said there have been four cases internationally, including two cases in Canada, of hepatitis associated with the 100 mg dose.